Revumenib
Revumenib SNDX-5613 2169919-21-3 LZ0M43NNF2 SNDX5613 C32H47FN6O4S, 630.82 SNDX-50613 free base SNDX-5613 free base SNDX50613 free base SNDX5613 free base FDA APPROVED 11/15/2024, Revuforj, To treat...
View ArticleBleximenib
Bleximenib CAS 2654081-35-1 WeightAverage: 599.796Monoisotopic: 599.395916661 Chemical FormulaC32H50FN7O3 CS-0636752 DA-55335 HY-148669 PHASE 3 JNJ-75276617; Menin-MLL inhibitor 24 Benzamide,...
View ArticleSulopenem
Sulopenem 120788-07-0 CP-70429 349.5 g/mol, C12H15NO5S3 XX514BJ1XW PF-03709270 PF03709270...
View ArticleProbenecid
Probenecid 57-66-9 4-(Dipropylsulfamoyl)benzoic acid Probenecid acid Benemid 4-(dipropylsulfamoyl)benzoic acid C13H19NO4S, 285.359 HC 5006 NSC-18786 FDA APPROVED, 10/25/2024, sulopenem etzadroxil,...
View ArticleTegeprotafib
Tegeprotafib CAS 2407610-46-0 Molecular Weight326.30FormulaC13H11FN2O5S PTPN2/1-IN-1, YGY4WEM0NZ 5-(1-fluoro-3-hydroxy-7-methoxynaphthalen-2-yl)-1,1-dioxo-1,2,5-thiadiazolidin-3-one Tegeprotafib...
View ArticleVanzacaftor
Vanzacaftor CAS 2374124-49-7 COM1POP492 VX-121 617.8 g/mol, C32H39N7O4S FDA APPROVED vanzacaftor, tezacaftor, and deutivacaftor, 12/20/2024, Alyftrek , To treat cystic fibrosis...
View ArticleBocodepsin
Bocodepsin, OKI-179 CAS 1834513-65-3 1834513-67-5 (besylate) K5D067O1SW S-((3E)-4-((6S,9S)-12,12-DIMETHYL-4,8,11,14-TETRAOXO-9-(PROPAN-2-YL)-7-OXA...
View ArticleInavolisib
Inavolisib WeightAverage: 407.378Monoisotopic: 407.140510438 Chemical FormulaC18H19F2N5O4 GDC-0077 CAS 2060571-02-8 GDC0077 RG6114 WHO 11204 GDC 0077 GDC-0077 RG-6114 RG6114 RO-7113755 RO7113755 FDA...
View ArticleBOFUTRELVIR
BOFUTRELVIR Cas 2103278-86-8 Molecular Weight452.55FormulaC25H32N4O4 UNII-T5UX5SKK2S; Mpro inhibitor 11A; 2103278-86-8; T5UX5SKK2S, DC-402234, DC402234, MPI-10 IUPAC/Chemical Name:...
View ArticleFlurpiridaz F 18
Flurpiridaz F 18 WeightAverage: 367.84Monoisotopic: 367.1328329 Chemical FormulaC18H22ClFN2O3 863887-89-2 Bms 747158-02...
View Article